Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects
about
Urate-lowering therapy for gout: focus on febuxostatManagement of hyperuricemia in gout: focus on febuxostat.Physicochemical properties of dietary phytochemicals can predict their passive absorption in the human small intestine.Effect of hydrochlorothiazide on the pharmacokinetics and pharmacodynamics of febuxostat, a non-purine selective inhibitor of xanthine oxidase.Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of febuxostat in human plasma.Ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of febuxostat in dog plasma and its application to a pharmacokinetic study.Febuxostat in the management of hyperuricemia and chronic gout: a review.Pharmacokinetics and Bioequivalence of Two Formulations of Febuxostat 40-Mg and 80-Mg Tablets: A Randomized, Open-Label, 4-Way Crossover Study in Healthy Chinese Male VolunteersPharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjectsEfficacy and safety of febuxostat in patients with hyperuricemia and gout.Pharmacokinetic(s) matters: stroke treatment et cetera.Pharmacokinetics and pharmacodynamics of febuxostat under fasting conditions in healthy individuals.Febuxostat: a new treatment for hyperuricaemia in gout.The challenges of gout management in the elderly.Clinically significant drug interactions with antacids: an update.Pharmacokinetics considerations for gout treatments.Urate-lowering therapy: current options and future prospects for elderly patients with gout.Febuxostat for the chronic management of hyperuricemia in patients with gout.An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015).Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat.Bioequivalance and pharmacokinetic study of febuxostat in human plasma by using LC-MS/MS with liquid liquid extraction method.Febuxostat methanol solvate.Febuxostat (Uloric), A New Treatment Option for Gout.Population Pharmacodynamic Analysis of Uric Acid-Lowering Effects of Febuxostat Based on Electronic Medical Records in Two Hospitals.Determination of Febuxostat in Human Plasma Using RP-LC-UV Method.Febuxostat, a novel drug for the treatment of hyperuricemia of goutMethod Development and Validation for Determination of Febuxostat from Spiked Human Plasma Using RP-HPLC with UV Detection
P2860
Q28283310-EEB949A2-3314-4807-91B0-88CF8C4F9B3DQ33635542-5163BEF1-139A-429B-B0D0-3F1402EC53B5Q33694804-12E3AA1A-C8EC-4230-A1B5-61746626A2D9Q34019336-9CF4F02F-4541-4AC3-AFCE-1D096D4B0EE6Q34279495-74969C02-3EE7-43B6-BD34-DCFEB58F2322Q34317925-D4511BFD-B653-4D0C-82AC-87DB1F997AB5Q34658300-BB85D34F-96C3-4DF7-A46D-A4C67E49EB6CQ35956067-866AD878-DE98-4C98-AFEC-C46C78AC54A4Q36029222-DE9237EE-BE48-4761-A100-7C16FAEE654AQ36059557-BE9BDC28-26C1-4ED5-B63D-288736810907Q36535917-BA06F1BD-30CB-4D7E-B05D-6610041E005CQ37434571-0593B8C6-DAA7-4C67-A1DD-84369B151A60Q37485326-1B845CE2-A122-4C41-837C-31D4AF4F6DB3Q37910891-13621DCA-C7F6-4E29-9051-BEC6BBF6DEEAQ37937722-C6EDEB04-11AD-433D-BCAD-7F534C519B50Q38210284-83500125-7F4F-44DD-ACE9-993CB1010001Q38254304-F0CD7F62-392E-4171-B12B-06AA453D0E24Q38760404-43EE6885-9EDC-4E3D-8B32-9A0457DD60B0Q39007529-258D5AB3-66B6-4A44-AB31-CA6F1023913DQ39278948-812BF37C-2B67-4CC4-B380-E62E3BCD78DBQ41047466-51E4B237-C5FA-4294-9EA6-0D575C9D2ED0Q41818582-8FA0D027-4761-4963-A3E5-B4FA5EABBBEDQ47122811-B9EB4C63-EF6F-475D-843F-602D9E3FB700Q47239976-B158699D-2532-400D-9D75-CD45A93DBD68Q53766440-77D03C62-56D7-4C93-9A1C-7DBAA118900EQ57076791-99A4129E-530D-4A54-B95D-1F42546B2E3AQ59036786-32BBA2F0-CC53-492A-8CF5-FC397853F435
P2860
Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Effect of food or antacid on p ...... febuxostat in healthy subjects
@ast
Effect of food or antacid on p ...... febuxostat in healthy subjects
@en
Effect of food or antacid on p ...... febuxostat in healthy subjects
@nl
type
label
Effect of food or antacid on p ...... febuxostat in healthy subjects
@ast
Effect of food or antacid on p ...... febuxostat in healthy subjects
@en
Effect of food or antacid on p ...... febuxostat in healthy subjects
@nl
prefLabel
Effect of food or antacid on p ...... febuxostat in healthy subjects
@ast
Effect of food or antacid on p ...... febuxostat in healthy subjects
@en
Effect of food or antacid on p ...... febuxostat in healthy subjects
@nl
P2093
P2860
P1476
Effect of food or antacid on p ...... febuxostat in healthy subjects
@en
P2093
Brian Grabowski
Jing-Tao Wu
Laurent Vernillet
Nancy Joseph-Ridge
Reza Khosravan
P2860
P304
P356
10.1111/J.1365-2125.2007.03016.X
P407
P577
2007-10-22T00:00:00Z